BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 22.804
AS - Asia 2.659
NA - Nord America 2.291
Continente sconosciuto - Info sul continente non disponibili 704
SA - Sud America 203
AF - Africa 55
OC - Oceania 5
Totale 28.721
Nazione #
IT - Italia 22.280
US - Stati Uniti d'America 2.130
SG - Singapore 1.092
CN - Cina 630
VN - Vietnam 388
BD - Bangladesh 246
FR - Francia 199
BR - Brasile 122
HK - Hong Kong 109
FI - Finlandia 80
DE - Germania 68
NL - Olanda 58
CA - Canada 56
AR - Argentina 35
JP - Giappone 33
MX - Messico 30
IQ - Iraq 26
ES - Italia 24
ID - Indonesia 23
IN - India 22
CH - Svizzera 17
GB - Regno Unito 17
GT - Guatemala 12
PH - Filippine 12
CO - Colombia 11
IE - Irlanda 10
JM - Giamaica 9
KE - Kenya 9
MA - Marocco 9
NP - Nepal 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
EC - Ecuador 8
SA - Arabia Saudita 8
AT - Austria 7
HN - Honduras 7
PY - Paraguay 7
RU - Federazione Russa 7
ZA - Sudafrica 7
PR - Porto Rico 6
TR - Turchia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
NI - Nicaragua 5
PK - Pakistan 5
PL - Polonia 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
MY - Malesia 4
SE - Svezia 4
UA - Ucraina 4
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
DZ - Algeria 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
UY - Uruguay 3
BE - Belgio 2
BJ - Benin 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
CD - Congo 2
IL - Israele 2
KN - Saint Kitts e Nevis 2
MD - Moldavia 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
SC - Seychelles 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
HU - Ungheria 1
IR - Iran 1
Totale 28.003
Città #
Genova 13.147
Genoa 5.475
Rapallo 1.871
Vado Ligure 1.422
Singapore 534
San Jose 440
Ashburn 284
Lauterbourg 183
Council Bluffs 123
Ho Chi Minh City 113
Hong Kong 103
New York 102
Hanoi 89
Beijing 88
Helsinki 72
Santa Clara 70
Bordighera 63
Frankfurt am Main 47
Amsterdam 42
Phoenix 38
Milan 32
Tokyo 30
Los Angeles 29
Dallas 27
Buffalo 19
Chicago 19
Da Nang 19
Rome 19
Naples 18
Houston 17
Mexico City 17
Haiphong 16
Tianjin 15
Zurich 15
Boardman 13
Biên Hòa 11
Bologna 11
Baghdad 10
Columbus 10
Dublin 10
Guatemala City 10
Atlanta 9
Las Vegas 9
Miami 9
Seattle 9
Shanghai 9
Can Tho 8
City of London 8
Durham 8
Jakarta 8
Lappeenranta 8
Newark 8
Orem 8
Santiago de Compostela 8
Washington 8
Baltimore 7
Brooklyn 7
Charlotte 7
Guangzhou 7
Kingston 7
Montreal 7
Orangeburg 7
Philadelphia 7
San Francisco 7
San José 7
The Bronx 7
Toronto 7
Berlin 6
Certaldo 6
Cincinnati 6
Hải Dương 6
Indpls 6
Nairobi 6
Tashkent 6
Turin 6
Brescia 5
Denver 5
Nuremberg 5
Queens 5
São Paulo 5
Tampa 5
Vancouver 5
Wilmington 5
Belo Horizonte 4
Brampton 4
Bắc Giang 4
Bắc Ninh 4
Cagliari 4
Cao Lanh 4
Cardiff 4
Ciudad del Este 4
Curitiba 4
Des Moines 4
Detroit 4
Federal Way 4
Fort Myers 4
Jacksonville 4
Jeddah 4
Louisville 4
Madrid 4
Totale 25.030
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 348
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 274
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users 214
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 212
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 208
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 208
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 206
Genuair® Usability Test: Results of a National Public Survey of the Elderly 204
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 204
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus 201
null 200
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 196
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 196
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 190
Antiallergic drugs and quality of life. 186
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 184
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 182
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 181
An update on allergen immunotherapy and asthma 180
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 180
Allergic diseases and their impact on quality of life. 177
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 177
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 175
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 175
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 174
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 173
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 173
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 170
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 170
Umeclidinium for the treatment of uncontrolled asthma 169
RhinAsthma patient perspective: A Rasch validation study 169
The relationship between allergen immunotherapy and omalizumab for treating asthma 168
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 168
Adherence to treatment: assessment of an unmet need in asthma. 167
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 167
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 166
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 166
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 165
Biosimilars in allergic diseases 165
Pidotimod: The state of art 164
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 164
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 164
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 164
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 163
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 163
Adherence to asthma treatments: 'We know, we intend, we advocate' 162
Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis. 162
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 159
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 158
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 158
Disease awareness in patients with COPD: measurement and extent 157
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 157
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 155
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 155
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 155
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 155
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 154
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab 152
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 152
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 152
Why do doctors and patients not follow guidelines? 151
Coping with asthma: is the physician able to identify patient's behaviour? 151
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 150
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 149
New therapies for allergic rhinitis 149
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 149
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 148
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Quality-of-life issues in survivors to anaphylactic reactions to drugs 147
Long-acting bronchodilators improve health related quality of life in patients with COPD. 147
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 146
Transoral glossoepiglottopexy in the treatment of adult obstructive sleep apnoea: A surgical approach [Glossoepiglottoplastica con approccio trans-orale nel trattamento delle apnee ostruttive notturne nell’adulto] 146
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 146
Patient-reported outcomes in asthma clinical trials 145
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 144
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 143
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 143
Asthma treatment: 'magic bullets which seek their own targets'. 143
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 143
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 143
Aqua©: Allergy questionnaire for athletes. Development and validation 142
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 142
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 142
Continuing Medical Education:an international reality 141
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 140
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 139
Phenotypes/endotypes-driven treatment in asthma 139
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 139
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 138
Rhinitis: Adherence to treatment and new technologies 138
Asthma management among different specialists: results from a national Italian survey 138
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 137
Sleep disturbances in allergic diseases. 136
Worldwide differences on the concept of control of asthma. 136
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 136
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 135
Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly 135
Totale 16.510
Categoria #
all - tutte 95.341
article - articoli 94.474
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 867
Totale 190.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.310 0 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20267.198 735 195 838 441 828 695 1.128 321 512 632 417 456
2026/2027964 791 173 0 0 0 0 0 0 0 0 0 0
Totale 28.721